General MedicationsORALGeneric
GEODON
ZIPRASIDONE HYDROCHLORIDE
Standard Dose
EQ 10MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: 901 REQUIRED Marketing status: Discontinued
Summary
Approval overview GEODON is listed in Drugs@FDA under application 021483 (NDA).
Review priority: 901 REQUIRED Marketing status: Discontinued Active ingredient ZIPRASIDONE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - EQ 10MG BASE/ML Sponsor PFIZER INC Submission history Latest submission status date: 2017-02-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview GEODON is listed in Drugs@FDA under application 021483 (NDA). Review priority: 901 REQUIRED Marketing status: Discontinued Active ingredient ZIPRASIDONE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - EQ 10MG BASE/ML Sponsor PFIZER INC Submission history Latest submission status date: 2017-02-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: 901 REQUIRED
Interaction Notes
- No interaction notes stored yet.